CTi Biopharma Corp (NASDAQ:CTIC)

Wednesday’s Trading Day
1.75 +0.09 / +5.42%
As of May 27
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
1.75 0.00 / 0.00%
 
Volume: 5.0K

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 4.50, with a high estimate of 8.00 and a low estimate of 3.50. The median estimate represents a +157.14% increase from the last price of 1.75.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$4.7M
Reporting Date
Jul 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.50%
 
 
 
 
 
 
Growthannually 42.46%
 
 
 
 
 
 

Sales

Growthquarterly 71.10%
 
 
 
 
 
 
Growthannually -9.35%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account